Immunic, Inc. (IMUX)
7.41
+0.42
(+6.01%)
USD |
NASDAQ |
Oct 20, 16:00
7.51
+0.10
(+1.35%)
After-Hours: 07:25
Immunic Gross Profit (TTM) : -0.149M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.149M |
| March 31, 2026 | -0.158M |
| December 31, 2025 | -0.168M |
| September 30, 2025 | -0.161M |
| June 30, 2025 | -0.163M |
| March 31, 2025 | -0.151M |
| December 31, 2024 | -0.134M |
| September 30, 2024 | -0.122M |
| June 30, 2024 | -0.114M |
| March 31, 2024 | -0.105M |
| December 31, 2023 | -0.111M |
| September 30, 2023 | -0.107M |
| June 30, 2023 | -0.09M |
| March 31, 2023 | -0.088M |
| December 31, 2022 | -0.077M |
| September 30, 2022 | -0.098M |
| June 30, 2022 | -0.097M |
| March 31, 2022 | -0.092M |
| December 31, 2021 | -0.085M |
| September 30, 2021 | -0.045M |
| June 30, 2021 | -0.072M |
| March 31, 2021 | -0.063M |
| December 31, 2020 | -0.063M |
| September 30, 2020 | -0.075M |
| June 30, 2020 | -0.041M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.059M |
| December 31, 2019 | -0.05M |
| September 30, 2019 | -0.043M |
| June 30, 2019 | -0.037M |
| March 31, 2019 | -0.017M |
| December 31, 2018 | -0.236M |
| September 30, 2018 | -0.449M |
| June 30, 2018 | -0.662M |
| March 31, 2018 | -0.887M |
| December 31, 2017 | -0.998M |
| September 30, 2017 | -1.184M |
| June 30, 2017 | -1.388M |
| March 31, 2017 | -1.649M |
| December 31, 2016 | -1.808M |
| September 30, 2016 | -1.785M |
| June 30, 2016 | -1.69M |
| March 31, 2016 | -1.528M |
| December 31, 2015 | -1.328M |
| September 30, 2015 | -1.181M |
| June 30, 2015 | -1.166M |
| March 31, 2015 | -1.084M |
| December 31, 2014 | -1.087M |
| September 30, 2014 | -1.084M |
| June 30, 2014 | -1.005M |
| March 31, 2014 | -0.933M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Sionna Therapeutics, Inc. | -0.561M |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |